Stierman B, Afful J, Carroll MD, Chen TC, Davy O, Fink S, Fryar CD, Gu Q, Hales CM, Hughes JP, Ostchega Y, Storandt RJ, Akinbami LJ, National Center for Health Statistics (U.S.). National health and nutrition examination survey 2017–march 2020 prepandemic data files development of files and prevalence estimates for selected health outcomes. Natl Health Stat Report. 2021. https://stacks.cdc.gov/view/cdc/106273.

Ward ZJ, Bleich SN, Long MW, Gortmaker SL. Association of body mass index with health care expenditures in the United States by age and sex. PLoS One. 2021;16(3):e0247307. PubMed PMID: 33760880. Pubmed Central PMCID: PMC7990296. Epub 20210324. eng.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cooke D, Bloom S. The obesity pipeline: current strategies in the development of anti-obesity drugs. Nat Rev Drug Discov. 2006;5(11):919–31. PubMed PMID: 17080028. eng.

Article  CAS  PubMed  Google Scholar 

Sargent BJ, Moore NA. New central targets for the treatment of obesity. Br J Clin Pharmacol. 2009;68(6):852–60. PubMed PMID: 20002079. Pubmed Central PMCID: PMC2810796. eng.

Article  CAS  PubMed  PubMed Central  Google Scholar 

•• Vosburg RW, El Chaar M, El Djouzi S, Docimo S Jr, Choi D, LaMasters T, et al. Literature review on antiobesity medication use for metabolic and bariatric surgery patients from the American Society for Metabolic and Bariatric Surgery Clinical Issues Committee. Surg Obes Relat Dis. 2022;18(9):1109–19. PubMed PMID: 36028428. Epub 20220714. eng. This review summarizes the anti-obesity pharmacotherapy options that available for use in bariatric surgery patients. It is highly relevant to the current review which analyzes publications on the topic of pharmacotherapy use in bariatric surgery patients.

Article  PubMed  Google Scholar 

Farzam K, Patel P. Tirzepatide. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright © 2023, StatPearls Publishing LLC.; 2023.

Khera R, Murad MH, Chandar AK, Dulai PS, Wang Z, Prokop LJ, et al. Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and meta-analysis. Jama. 2016;315(22):2424–34. PubMed PMID: 27299618. Pubmed Central PMCID: PMC5617638. eng.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alkhezi OS, Alahmed AA, Alfayez OM, Alzuman OA, Almutairi AR, Almohammed OA. Comparative effectiveness of glucagon-like peptide-1 receptor agonists for the management of obesity in adults without diabetes: a network meta-analysis of randomized clinical trials. Obes Rev. 2023;24(3):e13543. PubMed PMID: 36579723. Epub 20221229. eng.

Article  CAS  PubMed  Google Scholar 

Gloy VL, Briel M, Bhatt DL, Kashyap SR, Schauer PR, Mingrone G, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ : British Medical Journal. 2013;347:f5934.

Article  PubMed  PubMed Central  Google Scholar 

Sher T, Noom M, Diab A-R, Sujka J, Rinde-Hoffman D, DuCoin C. Efficacy of bariatric intervention as a bridge to cardiac transplant. surgery for obesity and related diseases. 2023;19(11):1296–301. https://doi.org/10.1016/j.soard.2023.05.013.

King WC, Hinerman AS, Belle SH, Wahed AS, Courcoulas AP. Comparison of the performance of common measures of weight regain after bariatric surgery for association with clinical outcomes. Jama. 2018;320(15):1560–9. PubMed PMID: 30326125. Pubmed Central PMCID: PMC6233795. eng.

Article  PubMed  PubMed Central  Google Scholar 

Sjöström L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683–93. PubMed PMID: 15616203. eng.

Article  PubMed  Google Scholar 

Sjöström L. Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery. J Intern Med. 2013;273(3):219–34. PubMed PMID: 23163728. Epub 20130208. eng.

Article  PubMed  Google Scholar 

Baig SJ, Priya P, Mahawar KK, Shah S. Weight regain after bariatric surgery-a multicentre study of 9617 patients from indian bariatric surgery outcome reporting group. Obes Surg. 2019;29(5):1583–92. PubMed PMID: 30729366. eng.

Article  PubMed  Google Scholar 

Nedelcu M, Khwaja HA, Rogula TG. Weight regain after bariatric surgery-how should it be defined? Surg Obes Relat Dis. 2016;12(5):1129–30. PubMed PMID: 27350180. Epub 20160429. eng.

Article  PubMed  Google Scholar 

El Ansari W, Elhag W. Weight regain and insufficient weight loss after bariatric surgery: definitions, prevalence, mechanisms, predictors, prevention and management strategies, and knowledge gaps-a scoping review. Obes Surg. 2021;31(4):1755–66. PubMed PMID: 33555451. Pubmed Central PMCID: PMC8012333. Epub 20210208. eng.

Article  PubMed  PubMed Central  Google Scholar 

Apovian CM. Obesity: definition, comorbidities, causes, and burden. Am J Manag Care. 2016;22(7 Suppl):s176–85. PubMed PMID: 27356115. eng.

PubMed  Google Scholar 

•• Elangovan A, Shah R, Smith ZL. Pharmacotherapy for obesity-trends using a population level national database. Obes Surg. 2021;31(3):1105–12. PubMed PMID: 32986169. Epub 20200928. eng. This is a large study on trends in pharmacotherapy usage in the United States, which is highly relevant background information for the current review.

Article  PubMed  Google Scholar 

Mosli MM, Elyas M. Does combining liraglutide with intragastric balloon insertion improve sustained weight reduction? Saudi J Gastroenterol. 2017;23(2):117–22. PubMed PMID: 28361843. Pubmed Central PMCID: PMC5385714. eng.

Article  PubMed  PubMed Central  Google Scholar 

Badurdeen D, Hoff AC, Barrichello S, Hedjoudje A, Itani MI, Farha J, et al. Efficacy of liraglutide to prevent weight regain after retrieval of an adjustable intra-gastric balloon-a case-matched study. Obes Surg. 2021;31(3):1204–13. PubMed PMID: 33211267. Epub 20201119. eng.

Article  PubMed  Google Scholar 

Badurdeen D, Hoff AC, Hedjoudje A, Adam A, Itani MI, Farha J, et al. Endoscopic sleeve gastroplasty plus liraglutide versus endoscopic sleeve gastroplasty alone for weight loss. Gastrointest Endosc. 2021;93(6):1316–24.e1. PubMed PMID: 33075366. Epub 20201017. eng.

Article  PubMed  Google Scholar 

Mehta A, Shah S, Dawod E, Hajifathalian K, Kumar R, Igel LI, et al. Impact of adjunctive pharmacotherapy with intragastric balloons for the treatment of obesity. Am Surg. 2023;89(4):707–13. PubMed PMID: 34384255. Epub 20210812. eng.

Article  PubMed  Google Scholar 

•• Redmond IP, Shukla AP, Aronne LJ. Use of weight loss medications in patients after bariatric surgery. Curr Obes Rep. 2021;10(2):81–9. PubMed PMID: 33492629. Epub 20210125. eng. Recent review on adjuvant pharmacotherapy used in combination with bariatric surgery. The current study is an update of the literature presented in this review.

Article  PubMed  Google Scholar 

•• Lucas E, Simmons O, Tchang B, Aronne L. Pharmacologic management of weight regain following bariatric surgery. Front Endocrinol (Lausanne). 2022;13:1043595. PubMed PMID: 36699042. Pubmed Central PMCID: PMC9868802. Epub 20230109. eng. Recent review on adjuvant pharmacotherapy used in combination with bariatric surgery. The current study is an update of the literature presented in this review.

Article  PubMed  Google Scholar 

Zilberstein B, Pajecki D, Garcia de Brito AC, Gallafrio ST, Eshkenazy R, Andrade CG. Topiramate after adjustable gastric banding in patients with binge eating and difficulty losing weight. Obes Surg. 2004;14(6):802–5. https://doi.org/10.1381/0960892041590926.

Miras AD, Pérez-Pevida B, Aldhwayan M, Kamocka A, McGlone ER, Al-Najim W, et al. Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 2019;7(7):549–59. PubMed PMID: 31174993. Epub 20190604. eng.

Article  CAS  PubMed  Google Scholar 

Colbourne JRM, Fisher OM, Mo S, Rigas GS, Talbot ML. The role of adjuvant pharmacotherapy with liraglutide for patients with inadequate weight loss following bariatric surgery. Langenbecks Arch Surg. 2023;408(1):115. PubMed PMID: 36867261. Pubmed Central PMCID: PMC9984502. Epub 20230303. eng.

Article  PubMed  PubMed Central  Google Scholar 

Rye P, Modi R, Cawsey S, Sharma AM. Efficacy of high-dose liraglutide as an adjunct for weight loss in patients with prior bariatric surgery. Obes Surg. 2018;28(11):3553–8. PubMed PMID: 30022424. eng.

Article  PubMed  Google Scholar 

Elhag W, El Ansari W, Abdulrazzaq S, Elsherif M, Mustafa I. Lorcaserin vs. Phentermine among non-surgical and surgical obese patients: anthropometric, glycemic, lipid, safety and cost outcomes. Ann Med Surg (Lond). 2019;45:75–81. PubMed PMID: 31388419. Pubmed Central PMCID: PMC6677860. Epub 20190713. eng.

Article  PubMed  Google Scholar 

Malone M, Alger-Mayer SA, Lindstrom J. Use of Orlistat 60 mg in the management of weight loss before bariatric surgery. Ann Pharmacother. 2012;46(6):779–84. PubMed PMID: 22570428. Epub 20120508. eng.

Article  PubMed  Google Scholar 

Sari C, Seip RL, Umashanker D. Case report: off label utilization of topiramate and metformin in patients with BMI ≥50 kg/m(2) prior to bariatric surgery. Front Endocrinol (Lausanne). 2021;12:588016. PubMed PMID: 33716960. Pubmed Central PMCID: PMC7947603. Epub 20210225. eng.

Article  PubMed  Google Scholar 

Cunningham JG, Szoka N, Tabone LE, Cox S, Aylward L, Abunnaja S. Preoperative and early adjuvant weight loss medications in bariatric surgery patients with body mass index over 60 or suboptimal initial response to surgery. Surg Obes Relat Dis. 2023. https://doi.org/10.1016/j.soard.2023.01.021.

Angelidi AM, Kokkinos A, Sanoudou D, Connelly MA, Alexandrou A, Mingrone G, et al. Early metabolomic, lipid and lipoprotein changes in response to medical and surgical therapeutic approaches to obesity. Metabolism. 2023;138:155346. PubMed PMID: 36375643. Epub 20221112. eng.

Article  CAS  PubMed  Google Scholar 

Jayaprakash MS, Beavers DP, Miller GD, McNatt S, Fernandez A, Edwards-Hampton SA, et al. Impact on cardiovascular health of using phentermine/topiramate in combination with laparoscopic sleeve gastrectomy in super obesity. J Surg Res. 2023;286:41–8. PubMed PMID: 36753948. Epub 20230206. eng.

Article  CAS  PubMed  Google Scholar 

Zoss I, Piec G, Horber FF. Impact of orlistat therapy on weight reduction in morbidly obese patients after implantation of the Swedish adjustable gastric band. Obes Surg. 2002;12(1):113–7. PubMed PMID: 11868286. eng.

Article  PubMed  Google Scholar 

Ard JD, Beavers DP, Hale E, Miller G, McNatt S, Fernandez A. Use of phentermine-topiramate extended release in combination with sleeve gastrectomy in patients with BMI 50 kg/m(2) or more. Surg Obes Relat Dis. 2019;15(7):1039–43. PubMed PMID: 31147285. Epub 20190419. eng.

Article  PubMed  Google Scholar 

Suliman M, Buckley A, Al Tikriti A, Tan T, le Roux CW, Lessan N, et al. Routine clinical use of liraglutide 3 mg for the treatment of obesity: outcomes in non-surgical and bariatric surgery patients. Diabetes Obes Metab. 2019;21(6):1498–501. PubMed PMID: 30768836. Epub 20190325. eng.

Article  CAS  PubMed  Google Scholar 

Thakur U, Bhansali A, Gupta R, Rastogi A. Liraglutide augments weight loss after laparoscopic sleeve gastrectomy: a randomised, double-blind, placebo-control study. Obes Surg. 2021;31(1):84–92. PubMed PMID: 32656729. Epub 20200712. eng.

Article  PubMed  Google Scholar 

Horber FF, Steffen R. Reversal of long-term weight regain after Roux-en-Y gastric bypass using liraglutide or surgical revision. a prospective study. Obes Surg. 2021;31(1):93–100. PubMed PMID: 32691401. Pubmed Central PMCID: PMC7808975. Epub 20200721. eng.

Article  PubMed  Google Scholar 

American Society for Metabolic and Bariatric Surgery. Estimate of bariatric surgery numbers, 2011–2021. American Society for Metabolic and Bariatric Surgery. 2020. [Online] https://asmbs.org/resources/estimate-of-bariatric-surgery-numbers. Accessed 1 Aug 2023.